These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32145686)

  • 1. Monobodies as enabling tools for structural and mechanistic biology.
    Hantschel O; Biancalana M; Koide S
    Curr Opin Struct Biol; 2020 Feb; 60():167-174. PubMed ID: 32145686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monobodies as tool biologics for accelerating target validation and druggable site discovery.
    Akkapeddi P; Teng KW; Koide S
    RSC Med Chem; 2021 Nov; 12(11):1839-1853. PubMed ID: 34820623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective Targeting of SH2 Domain-Phosphotyrosine Interactions of Src Family Tyrosine Kinases with Monobodies.
    Kükenshöner T; Schmit NE; Bouda E; Sha F; Pojer F; Koide A; Seeliger M; Koide S; Hantschel O
    J Mol Biol; 2017 May; 429(9):1364-1380. PubMed ID: 28347651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Teaching an old scaffold new tricks: monobodies constructed using alternative surfaces of the FN3 scaffold.
    Koide A; Wojcik J; Gilbreth RN; Hoey RJ; Koide S
    J Mol Biol; 2012 Jan; 415(2):393-405. PubMed ID: 22198408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of single- and double-sided inhibition of dual topology fluoride channels by synthetic monobodies.
    Turman DL; Stockbridge RB
    J Gen Physiol; 2017 Apr; 149(4):511-522. PubMed ID: 28258203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Differentiation in Monobodies Based on the Fibronectin Type 3 Domain.
    Chandler PG; Buckle AM
    Cells; 2020 Mar; 9(3):. PubMed ID: 32143310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational and biophysical robustness in a prestabilized monobody.
    Chandler PG; Tan LL; Porebski BT; Green JS; Riley BT; Broendum SS; Hoke DE; Falconer RJ; Munro TP; Buckle M; Jackson CJ; Buckle AM
    J Biol Chem; 2021; 296():100447. PubMed ID: 33617878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monobodies: antibody mimics based on the scaffold of the fibronectin type III domain.
    Koide A; Koide S
    Methods Mol Biol; 2007; 352():95-109. PubMed ID: 17041261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition of STAT3 signaling using monobodies targeting the coiled-coil and N-terminal domains.
    La Sala G; Michiels C; Kükenshöner T; Brandstoetter T; Maurer B; Koide A; Lau K; Pojer F; Koide S; Sexl V; Dumoutier L; Hantschel O
    Nat Commun; 2020 Aug; 11(1):4115. PubMed ID: 32807795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein binders and their applications in developmental biology.
    Harmansa S; Affolter M
    Development; 2018 Jan; 145(2):. PubMed ID: 29374062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Phage Display and Other Molecular Display Methods for the Development of Monobodies.
    Koide A; Koide S
    Cold Spring Harb Protoc; 2024 May; 2024(5):107982. PubMed ID: 37137569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of monobody scaffold interactions with ligand via force spectroscopy and steered molecular dynamics.
    Cheung LS; Shea DJ; Nicholes N; Date A; Ostermeier M; Konstantopoulos K
    Sci Rep; 2015 Feb; 5():8247. PubMed ID: 25650239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dominant conformational role for amino acid diversity in minimalist protein-protein interfaces.
    Gilbreth RN; Esaki K; Koide A; Sidhu SS; Koide S
    J Mol Biol; 2008 Aug; 381(2):407-18. PubMed ID: 18602117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cork-in-Bottle Occlusion of Fluoride Ion Channels by Crystallization Chaperones.
    McIlwain BC; Newstead S; Stockbridge RB
    Structure; 2018 Apr; 26(4):635-639.e1. PubMed ID: 29526432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allosteric modulation of a human protein kinase with monobodies.
    Zorba A; Nguyen V; Koide A; Hoemberger M; Zheng Y; Kutter S; Kim C; Koide S; Kern D
    Proc Natl Acad Sci U S A; 2019 Jul; 116(28):13937-13942. PubMed ID: 31239342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monobodies and other synthetic binding proteins for expanding protein science.
    Sha F; Salzman G; Gupta A; Koide S
    Protein Sci; 2017 May; 26(5):910-924. PubMed ID: 28249355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-affinity single-domain binding proteins with a binary-code interface.
    Koide A; Gilbreth RN; Esaki K; Tereshko V; Koide S
    Proc Natl Acad Sci U S A; 2007 Apr; 104(16):6632-7. PubMed ID: 17420456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of MLKL membrane translocation as a checkpoint in necroptotic cell death using Monobodies.
    Petrie EJ; Birkinshaw RW; Koide A; Denbaum E; Hildebrand JM; Garnish SE; Davies KA; Sandow JJ; Samson AL; Gavin X; Fitzgibbon C; Young SN; Hennessy PJ; Smith PPC; Webb AI; Czabotar PE; Koide S; Murphy JM
    Proc Natl Acad Sci U S A; 2020 Apr; 117(15):8468-8475. PubMed ID: 32234780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving the pharmacokinetics, biodistribution and plasma stability of monobodies.
    Dinh-Fricke AV; Hantschel O
    Front Pharmacol; 2024 Apr; 15():. PubMed ID: 38617793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibronectin type III domain based monobody with high avidity.
    Duan J; Wu J; Valencia CA; Liu R
    Biochemistry; 2007 Nov; 46(44):12656-64. PubMed ID: 17929945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.